ENTITY
Bayer

Bayer (BAYN GR)

70
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
•23 Dec 2019 05:16

Political Pit Stop 2020: Power Concentrates For the Thai Government

As the year closes, we note the five recent political developments in Thailand. On the balance, it leads to a stronger government and weaker...

bullish•MSCI World Index
•11 Dec 2019 07:37

Global Equities Headed Up and to the Right: Technology, Health Care Leading

Our weight of the evidence approach leads us to believe the market remains in the early stages of a broad-based advance, meaning a buy-the-dip...

Logo
556 Views
Share
bullish•MSCI ACWI Index
•22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
450 Views
Share
•14 Aug 2019 16:45

CStone Pharma's (基石药业) Lock-Up Expiry - Lack of Material Newsflow for Core Drug Candidates

Lock-up restriction for Cstone Pharma's pre-IPO investors and cornerstone investors will expire on August 26th. As we expect roughly USD 1 billion...

Logo
678 Views
Share
bullish•DowDuPont Inc
•05 Jun 2019 01:09

SpinTalk: Focus On Corteva Agriscience (CTVA US) - An Attractive Long Term Investment Proposition

The Creation Of A Unique Pure-Play AgribusinessSome 20 months after Dow Chemicals and DuPont completed their ‘Merger of Equals’ in August 2017 to...

Logo
730 Views
Share
x